Corticosteroids Market
Corticosteroids Market Size, Share & Trends Analysis Report, By Product Type (Glucocorticoids, Mineralocorticoids), By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Diseases, Allergic Conditions, Endocrine Disorders), By Drug Class Potency (Low Potency, Medium Potency, High Potency), By Formulation Type (Solid Formulations, Liquid Formulations, Semi-Solid, Aerosol/Inhalers), Forecast Period (2026-2035)
Industry Overview
Corticosteroids market size was valued at $6.20 billion in 2025 and is projected to reach $10.29 billion by 2035, growing at a CAGR of 5.2% between 2026 and 2035. The market consists of steroid-based anti-inflammatory and immunosuppressive drugs used widely across respiratory, dermatological, autoimmune, and endocrine disorders. A key driver supporting market growth is the increasing global prevalence of chronic inflammatory and respiratory diseases. According to the World Health Organisation, over 550 million people globally suffer from chronic respiratory diseases, including asthma and COPD, highlighting a strong and sustained demand for corticosteroid-based therapies. Additionally, asthma affects more than 260 million individuals worldwide, requiring long-term corticosteroid treatment for effective disease management. The increasing burden of autoimmune diseases and allergic conditions is further strengthening market demand. The European Federation of Pharmaceutical Industries and Associations highlights continuous growth in pharmaceutical R&D investments, particularly in immunology and anti-inflammatory therapies. Corticosteroids are increasingly adopted across hospitals, clinics, and home care settings due to their effectiveness in controlling inflammation and improving patient outcomes. Advancements in drug delivery technologies, including inhalers, topical creams, and sustained-release formulations, are further enhancing treatment efficiency and patient compliance.
Market Dynamics
Rising Prevalence of Chronic Diseases Driving Market Growth
The growing prevalence of chronic inflammatory and respiratory diseases is a primary driver of the Corticosteroids market. According to the World Health Organisation, chronic diseases account for nearly 74% of global deaths, with respiratory and autoimmune disorders contributing significantly to this burden. Increasing air pollution, urbanisation, and lifestyle changes are driving a higher incidence of asthma, COPD, and allergic conditions globally. Between 2025 and 2026, pharmaceutical companies are focusing on expanding inhaled corticosteroid therapies and combination treatments to enhance effectiveness. The U.S. Food and Drug Administration continues to approve advanced corticosteroid formulations, particularly inhalers and topical drugs, supporting innovation. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations reports increasing investment in immunology therapies, further driving corticosteroid demand globally.
Side Effects and Regulatory Complexities Limiting Market Growth
Despite strong demand, the Corticosteroids market faces challenges related to long-term side effects and regulatory complexities. Prolonged use of corticosteroids can lead to complications such as osteoporosis, hypertension, diabetes, and immune suppression, limiting their use in chronic treatments. According to insights from the Organisation for Economic Co-operation and Development, managing adverse drug reactions remains a critical challenge in chronic disease management. Additionally, stringent regulatory requirements for drug approvals and safety monitoring increase development costs and timelines. Supply chain dependencies on active pharmaceutical ingredients (APIs) further add cost pressures. To overcome these challenges, companies are focusing on low-dose formulations, targeted delivery systems, and combination therapies to improve safety and efficacy.
Market Segmentation
- Based on the product type, the market is segmented into glucocorticoids and mineralocorticoids.
- Based on the application, the market is segmented into respiratory diseases, dermatological disorders, autoimmune & inflammatory diseases, allergic conditions, and endocrine disorders.
- Based on the drug class potency, the market is segmented into low potency corticosteroids, medium potency corticosteroids, and high potency corticosteroids.
- Based on the formulation type, the market is segmented into solid formulations, liquid formulations, semi-solid, and aerosol / inhalers.
Glucocorticoids Segment Leads the Market
The glucocorticoids segment holds a dominant position in the Corticosteroids market due to its extensive use in treating respiratory and autoimmune diseases. These drugs are widely prescribed for asthma, COPD, rheumatoid arthritis, and inflammatory disorders due to their strong anti-inflammatory properties. Increasing disease prevalence is significantly driving adoption. Between 2022 and 2026, pharmaceutical companies have expanded glucocorticoid-based inhalers and topical formulations to improve treatment outcomes. Companies such as Pfizer Inc. and AstraZeneca plc are focusing on innovation in drug delivery systems to strengthen their market position.
Aerosol / Inhalers Segment to Record Strong Growth
The aerosol/inhalers segment is expected to witness the fastest growth due to increasing demand for targeted drug delivery systems. Inhaled corticosteroids enable direct delivery to the lungs, improving therapeutic efficacy and reducing systemic side effects. Advancements in inhaler technologies and rising patient preference for non-invasive treatments are driving adoption. Increasing investments in respiratory healthcare and expanding access in emerging economies are further supporting growth.
Regional Outlook
The global Corticosteroids market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the Corticosteroids market due to its advanced healthcare infrastructure and high prevalence of chronic diseases. According to the U.S. Food and Drug Administration, continuous approvals of corticosteroid-based drugs are supporting innovation and market growth. Strong presence of leading pharmaceutical companies and high healthcare expenditure further drives demand.
China to Record Strong Growth
China is expected to witness strong growth due to expanding pharmaceutical manufacturing and healthcare infrastructure. According to the International Trade Centre, China is strengthening pharmaceutical exports and production capabilities. Rising respiratory disease burden and increasing healthcare investments are driving demand for corticosteroids.
Competitive Landscape
The corticosteroid market is highly competitive, characterised by strong product portfolios and continuous innovation. Leading companies such as Pfizer Inc., GSK plc, AstraZeneca plc, Sanofi, and Cipla Ltd. maintain strong market positions through R&D investments, product launches, and strategic collaborations. These companies are focusing on expanding respiratory and dermatology portfolios while improving drug delivery systems.
Recent Developments
- In January 2026, AstraZeneca reported positive Phase III TULIP-SC trial results for Saphnelo, showing reduced disease activity and enabling oral corticosteroid reduction in SLE patients, strengthening its immunology portfolio.
- In December 2025, GSK plc received FDA approval for Exdensur (depemokimab) based on Phase III SWIFT trials, showing up to 58% reduction in asthma exacerbations with just two doses per year, enhancing patient outcomes and reducing treatment burden in severe asthma care.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualised market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global corticosteroids market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Corticosteroids Market Sales Analysis – Product Type | Application | Drug Class Potency | Formulation Type ($ Million)
- Corticosteroids Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
1.2 Market Snapshot
- Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Corticosteroids Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Corticosteroids Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
- Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Corticosteroids Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Corticosteroids Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Corticosteroids Market: Impact Analysis
- Competitive Landscape
4.1 Competitive Dashboard – Corticosteroids Market Revenue and Share by Manufacturers
- Corticosteroids Product Comparison Analysis
- Top Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Pfizer Inc.
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 GSK plc
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 AstraZeneca plc
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Sanofi
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 Cipla Ltd.
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
- Global Corticosteroids Market Sales Analysis by Product Type ($ Million)
5.1 Glucocorticoids
5.2 Mineralocorticoids
- Global Corticosteroids Market Sales Analysis by Application ($ Million)
6.1 Respiratory Diseases
6.2 Dermatological Disorders
6.3 Autoimmune & Inflammatory Diseases
6.4 Allergic Conditions
6.5 Endocrine Disorders
- Global Corticosteroids Market Sales Analysis by Drug Class Potency ($ Million)
7.1 Low Potency Corticosteroids
7.2 Medium Potency Corticosteroids
7.3 High Potency Corticosteroids
- Global Corticosteroids Market Sales Analysis by Formulation Type ($ Million)
8.1 Solid Formulations
8.2 Liquid Formulations
8.3 Semi-Solid
8.4 Aerosol / Inhalers
- Regional Analysis
9.1 North American Corticosteroids Market Sales Analysis – Product Type | Application | Drug
Class Potency | Formulation Type ($ Million)
9.1.1 United States
9.1.2 Canada
9.2 European Corticosteroids Market Sales Analysis – Product Type | Application | Drug Class
Potency | Formulation Type ($ Million)
9.2.1 UK
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 France
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific Corticosteroids Market Sales Analysis – Product Type | Application | Drug Class
Potency | Formulation Type ($ Million)
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 ASEAN Countries
9.3.7 Rest of Asia-Pacific
9.4 Rest of the World Corticosteroids Market Sales Analysis – Product Type | Application |
Drug Class Potency | Formulation Type ($ Million)
9.4.1 Latin America
9.4.2 Middle East and Africa
- Company Profiles
10.1 Alkem Laboratories Ltd.
10.1.1 Quick Facts
10.1.2 Company Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.2 Amneal Pharmaceuticals, Inc.
10.2.1 Quick Facts
10.2.2 Company Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.3 Apotex Inc.
10.3.1 Quick Facts
10.3.2 Company Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.4 Aurobindo Pharma Ltd.
10.4.1 Quick Facts
10.4.2 Company Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.5 Bausch Health Companies Inc.
10.5.1 Quick Facts
10.5.2 Company Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.6 Dr Reddy’s Laboratories Ltd.
10.6.1 Quick Facts
10.6.2 Company Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.7 Galderma S.A.
10.7.1 Quick Facts
10.7.2 Company Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.8 Glenmark Pharmaceuticals Ltd.
10.8.1 Quick Facts
10.8.2 Company Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.9 Hikma Pharmaceuticals PLC
10.9.1 Quick Facts
10.9.2 Company Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.10 LEO Pharma A/S
10.10.1 Quick Facts
10.10.2 Company Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.11 Lupin Limited
10.11.1 Quick Facts
10.11.2 Company Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.12 Mallinckrodt plc
10.12.1 Quick Facts
10.12.2 Company Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.13 Merck & Co., Inc.
10.13.1 Quick Facts
10.13.2 Company Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.14 Novartis AG
10.14.1 Quick Facts
10.14.2 Company Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.15 Organon & Co.
10.15.1 Quick Facts
10.15.2 Company Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.16 Perrigo Company plc
10.16.1 Quick Facts
10.16.2 Company Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.17 Sun Pharmaceutical Industries Ltd.
10.17.1 Quick Facts
10.17.2 Company Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.18 Teva Pharmaceutical Industries Ltd.
10.18.1 Quick Facts
10.18.2 Company Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.19 Viatris Inc.
10.19.1 Quick Facts
10.19.2 Company Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.20 Zydus Lifesciences Ltd.
10.20.1 Quick Facts
10.20.2 Company Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
1. Global Corticosteroids Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global Glucocorticoids Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Mineralocorticoids Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Corticosteroids Market Research and Analysis by Application, 2025–2035 ($ Million)
5. Global Corticosteroids for Respiratory Diseases Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Corticosteroids for Dermatological Disorders Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Corticosteroids for Autoimmune & Inflammatory Diseases Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Corticosteroids for Allergic Conditions Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Corticosteroids for Endocrine Disorders Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Corticosteroids Market Research and Analysis by Drug Class Potency, 2025–2035 ($ Million)
11. Global Low Potency Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Medium Potency Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global High Potency Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Corticosteroids Market Research and Analysis by Formulation Type, 2025–2035 ($ Million)
15. Global Solid Formulations Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Liquid Formulations Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Semi-Solid Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Aerosol / Inhalers Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
19. Global Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
20. North America Corticosteroids Market Research and Analysis by Country, 2025–2035 ($ Million)
21. North America Corticosteroids Market Research and Analysis by Product Type, 2025–2035 ($ Million)
22. North America Corticosteroids Market Research and Analysis by Application, 2025–2035 ($ Million)
23. North America Corticosteroids Market Research and Analysis by Drug Class Potency, 2025–2035 ($ Million)
24. North America Corticosteroids Market Research and Analysis by Formulation Type, 2025–2035 ($ Million)
25. Europe Corticosteroids Market Research and Analysis by Country, 2025–2035 ($ Million)
26. Europe Corticosteroids Market Research and Analysis by Product Type, 2025–2035 ($ Million)
27. Europe Corticosteroids Market Research and Analysis by Application, 2025–2035 ($ Million)
28. Europe Corticosteroids Market Research and Analysis by Drug Class Potency, 2025–2035 ($ Million)
29. Europe Corticosteroids Market Research and Analysis by Formulation Type, 2025–2035 ($ Million)
30. Asia-Pacific Corticosteroids Market Research and Analysis by Country, 2025–2035 ($ Million)
31. Asia-Pacific Corticosteroids Market Research and Analysis by Product Type, 2025–2035 ($ Million)
32. Asia-Pacific Corticosteroids Market Research and Analysis by Application, 2025–2035 ($ Million)
33. Asia-Pacific Corticosteroids Market Research and Analysis by Drug Class Potency, 2025–2035 ($ Million)
34. Asia-Pacific Corticosteroids Market Research and Analysis by Formulation Type, 2025–2035 ($ Million)
35. Rest of the World Corticosteroids Market Research and Analysis by Region, 2025–2035 ($ Million)
36. Rest of the World Corticosteroids Market Research and Analysis by Product Type, 2025–2035 ($ Million)
37. Rest of the World Corticosteroids Market Research and Analysis by Application, 2025–2035 ($ Million)
38. Rest of the World Corticosteroids Market Research and Analysis by Drug Class Potency, 2025–2035 ($ Million)
39. Rest of the World Corticosteroids Market Research and Analysis by Formulation Type, 2025–2035 ($ Million)
1. Global Corticosteroids Market Share by Segment, 2025 Vs 2035 (%)
2. Global Glucocorticoids Market Share by Region, 2025 Vs 2035 (%)
3. Global Mineralocorticoids Market Share by Region, 2025 Vs 2035 (%)
4. Global Corticosteroids for Respiratory Diseases Market Share by Region, 2025 Vs 2035 (%)
5. Global Corticosteroids for Dermatological Disorders Market Share by Region, 2025 Vs 2035 (%)
6. Global Corticosteroids for Autoimmune & Inflammatory Diseases Market Share by Region, 2025 Vs 2035 (%)
7. Global Corticosteroids for Allergic Conditions Market Share by Region, 2025 Vs 2035 (%)
8. Global Corticosteroids for Endocrine Disorders Market Share by Region, 2025 Vs 2035 (%)
9. Global Low Potency Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
10. Global Medium Potency Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
11. Global High Potency Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
12. Global Solid Formulations Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
13. Global Liquid Formulations Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
14. Global Semi-Solid Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
15. Global Aerosol / Inhalers Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
16. Global Corticosteroids Market Share by Region (%)
17. United States Corticosteroids Market Size, 2025–2035 ($ Million)
18. Canada Corticosteroids Market Size, 2025–2035 ($ Million)
19. UK Corticosteroids Market Size, 2025–2035 ($ Million)
20. France Corticosteroids Market Size, 2025–2035 ($ Million)
21. Germany Corticosteroids Market Size, 2025–2035 ($ Million)
22. Italy Corticosteroids Market Size, 2025–2035 ($ Million)
23. Spain Corticosteroids Market Size, 2025–2035 ($ Million)
24. Russia Corticosteroids Market Size, 2025–2035 ($ Million)
25. India Corticosteroids Market Size, 2025–2035 ($ Million)
26. China Corticosteroids Market Size, 2025–2035 ($ Million)
27. Japan Corticosteroids Market Size, 2025–2035 ($ Million)
28. South Korea Corticosteroids Market Size, 2025–2035 ($ Million)
29. Australia & New Zealand Corticosteroids Market Size, 2025–2035 ($ Million)
30. ASEAN Corticosteroids Market Size, 2025–2035 ($ Million)
31. Rest of Asia-Pacific Corticosteroids Market Size, 2025–2035 ($ Million)
32. Latin America Corticosteroids Market Size, 2025–2035 ($ Million)
33. Middle East & Africa Corticosteroids Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
